Bootstrapping in Texas - Why FYX Lab Ops Wanted to Launch in the Lone Star State

Written By Kathleen Otto

By J. Riggs, CEO of FYX

Ranking opportunities in life can be a tenuous between making sound financial decisions and reckless optimism. Years ago, I chose to accelerate my career as an operations specialist by moving to Boston and working for some of the largest biotech firms in the nation. An important factor in that decision was the relative imbalance I found then between opportunities in my home of Texas and what New England offered an ambitious, hardworking, science professional. Nearly three years of consulting for the industry has revealed a stark contrast between the biotech sector in Texas and the northeast. 

A new dawn is emerging in Texas biotech and exciting progress is on our horizon. Right now, Texas is in the ideal place to facilitate our success…

Kathleen Otto
Previous

Southwestern Medical Foundation, The Cary Council and UT Southwestern Announce $50,000 DocStar Grant Recipients Supporting Early Stage Biomedical Research in Texas
Next

UT Southwestern Receives $50M from the Perot Family to Expand their Medical Scientist Training Program